A
VMD icon

AJOVista’s Viemed Healthcare VMD Stock Holding History

AJOVista’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,351
Closed -$42K – 413
2023
Q4 		$42K Buy
+5,351
New +$38.8K 0.05% 312

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

AJOVista's VMD Position: Q1 2024 in Review

AJOVista sold out of Viemed Healthcare (VMD) in Q1 2024, closing a stake of 5,351 shares — an estimated $42K sold.

AJOVista first reported a position in VMD in Q4 2023 and held it in 1 quarter. The position peaked at $42K in Q4 2023. 112 funds tracked by Wall St. Rank hold VMD as of Q1 2024.

  • AJOVista reported no remaining Viemed Healthcare position as of Q1 2024 after selling out during the quarter.
  • AJOVista sold 5,351 Viemed Healthcare shares in Q1 2024, an estimated $42K.
  • AJOVista first reported a position in Viemed Healthcare in Q4 2023 and held it in 1 quarter.
  • AJOVista's Viemed Healthcare position peaked at $42K in Q4 2023.
  • 112 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.